Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds were found to build bone and muscle without affecting reproductive organs and skin oil glands.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

CAG repeat polymorphism and prostate zone volume are not reliable markers of long-term androgen sensitivity.

Human hair growth is influenced by androgen hormones, and red deer mane follicles have similar hormone receptors.

A point mutation in the androgen receptor gene causes complete androgen insensitivity.

Androgen receptor signaling causes early aging of cells important for hair growth by damaging their DNA.

Human keratinocytes do not naturally respond to androgens.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Two gene areas linked to male pattern baldness found, more research needed.

Certain gene variations are not a major cause of male infertility in Nigerian men.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Finasteride changes androgen receptor location in rat epididymis without altering tissue structure.

Men with hair loss have more DNA changes in back-of-head hair follicles, possibly protecting them from thinning.

Red deer only have androgen receptors in neck hair cells for mane growth during breeding season.

DHT stops hair regrowth in mice, similar to human hair loss.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Testosterone reduces knee flexibility by affecting relaxin receptors.

AR gene not major factor in female hair loss; different from male hair loss.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Spironolactone reduces the number of androgen receptor sites in rat skin by blocking them with its metabolite.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Certain changes to the B-ring of androgen receptor ligands can increase their effectiveness for potential treatments of muscle and bone conditions.

The study concludes that a genetic mutation in TFM mice leads to reduced androgen receptor activity, affecting the body's response to male hormones.

Certain progesterone derivatives can inhibit enzymes and reduce androgenic activity, potentially affecting prostate growth.

PGD2 increases androgen receptor activity in hair cells, which could be targeted to treat hair loss.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Longer CAG and GGN repeats increase alopecia risk, but no significant link to post-finasteride syndrome found.

Women with greater androgen sensitivity respond better to finasteride for hair loss.

Scientists restored fertility in male mice lacking a key fertility gene by using a modified gene.